Medical Treatment for Stroke Prevention
Ann Int Med 121:41-55, Matchar,D.B.,et al, 1994
Cardiovasc Causes of Loss of Consciousness in Pts with Presumed Epilepsy:Cause of Incr Sudden Death in Epilepsy?
Am J Med 96:146-154, Linzer,M.,et al, 1994
Warfarin Versus Aspirin for Prevention of Thromboembolism in Atrial Fibrillation:SPAF II Study
SPAF-II Investigators, Lancet 343:687-691, 683994., , 1994
Stroke Prevention an Opportunity for Efficient Utilization of Health Care Resources During the Coming Decade
Stroke 25:220-224, Gorelick,P.B., 1994
Managing Chronic Atrial Fibrillation:A Markov Decision Analysis Comparing Warfarin, Quinidine, and Low-Dose Amiodarone
Ann Int Med 120:449-457, Disch,D.L.,et al, 1994
Myotonic Dystrophy
In Myology, Engel & Franzini-Armstrong, McGraw-Hill, Inc, New York V2, Ch 43, P1192, Harper,P.S.&Rudel,R., 1994
Secondary Prevention in Non-Rheumatic Atrial Fib After TIA or Minor Stroke
European Atrial Fibrillation Trial Study Group, Lancet 342:1255-1262, 1251-1252993., , 1993
Effect of Low-Intensity Warfarin Anticoag on Level of Activity of Hemostatic System in Pts with Atrial Fib
Stroke 24:1360-1365, Kistler,J.P.,et al, 1993
Brain Embolism, Revisited
Neurol 43:1281-1287, Caplan,L., 1993
Sudden Death of a Carrier of X-Linked Emery-Dreifuss Muscular Dystrophy
Ann Int Med 119:900-905, Fishbein,M.C.,et al, 1993
Radiofrequency Ablation of Kent's Pathways. Apropos of 30 Cases
Arch Mal Coeur Vaiss 86:307-312, Sadoul,N.,et al, 1993
Cardiogenic Embolism to the Brain
Lancet 339:589-594, Hart,R.G., 1992
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Predictors of Thromboembolism in Atrial Fib:II. Echocard Features of Pts at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:6-121992., , 1992
Thyrotoxic Periodic Paralysis in the US, Report of 7 Cases & Review of the Literature
Medicine 71:109-120, Ober,K.P., 1992
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992
Warfarin in the Prevention of Stroke Associated with Nonrheumatic Atrial Fibrillation
NEJM 327:1406-1412, 14511992., Ezekowitz,M.D.,et al, 1992
Evaluation and Management of the Patient with Syncope
JAMA 268:2553-2560, Kapoor,W.N., 1992
Stroke Prevention in Nonvalvular Atrial Fibrillation:A Review of Prospective Randomized Trials
Ann Neurol 30:511-518, Albers,G.W.,et al, 1991
Influence of Low-Intensity Warfarin Treatment of Patients'Perceptions of Quality of Life
Editorial, Arch Int Med 151:1921-1922, 1944-1949991., , 1991
Stroke Prevention in Nonvalvular Atrial Fibrillation
Ann Int Med 115:727-736, Albers,G.W.,et al, 1991
Physicians'Attitudes Toward Anticoag & Antiplat Agents for Stroke Prevent in Elderly Pts with Atrial Fib
Arch Int Med 151:1950-1953, 19221991., Kutner,M.,et al, 1991
Polymyositis, Dermatomyositis, and Inclusion-Body Myositis
NEJM 325:1487-1498, Dalakas,M.C., 1991
Eosinophilia-Myalgia Syndrome, A Clinical Case Series of 21 Patients
Arch Int Med 151:533-537, Philen,R.M.,et al, 1991
Atrial Fibrillation as an Independent Risk Factor for Stroke:The Framingham Study
Stroke 22:983-988, Wolf,P.A.,et al, 1991
Syncope:1991
Am J Med 90:1-5, Linzer,M., 1991
Syncope:Current Diagnostic Evaluation and Management
Ann Int Med 112:850-863, Manolis,A.S.,et al, 1990
Acute Intermittent Porphyria
JAMA 264:1290-1293, 1315-13161990., Sack,G.H., 1990
The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation
NEJM 323:1505-1511, 1556-15581990., Kistler,J.P.,et al, 1990
Thromboembolic Complications in Atrial Fibrillation
Stroke 21:4-13, Petersen,P., 1990
Preliminary Report of the Stroke Prevention in Atrial Fibrillation Study
Study Group, NEJM 322:863-8681990., , 1990
Variables Predicting Surgical Outcome in Symptomatic Hydrocephalus in the Elderly
Neurol 39:1601-1604, Graff-Radford,R.N.,et al, 1989
Current Concepts in the Idiopathic Inflammatory Myopathies:Polymyositis, Dermatomyositis, and Related Disorders
Ann Int Med 111:143-157, Plotz,P.H.,et al, 1989
A Mitochondrial DNA Mutation as a Cause of Leber's Hereditary Optic Neuropathy
NEJM 320:1300-1305, Singh,G.,et al, 1989
Placebo-Controlled, Randomised Trial of Warfarin & ASA for Prevention of Thromboembolic Complic in Chronic A Fib
Lancet 1:175-179, Petersen,P.,et al, 1989
Cardiogenic Brain Embolism
The Second Report of the Cerebral Embolism Task Force, Cerebral Embolism Task Force, Arch Neurol 46:, 2743,1989., 1989
Anticoagulant Drugs in the Elderly, Controversies in Therapeutics
BMJ 297:1260-1263, Lowe,G.D.O.&Scott,P.J.W., 1988
Anticoagulation of Embolic Strokes of Cardiac Origin:An Update
Neurol 38:314-316, Yatsu,F.M.,et al, 1988
Prevalence of Patent Foramen Ovale in Patients with Stroke
NEJM 318:1148-1152, 11971988., Lechat,P.,et al, 1988
Stroke in Thyrotoxicosis with Atrial Fibrillation
Stroke 19:15-18, Petersen,P.&Hansen,J.M., 1988
Cardiovascular Autonomic Dysfunction in Guillain-Barre Syndrome, Therapeutic Implications of Swan-Ganz Monitoring
Arch Neurol 45:115-117, Dalos,N.P.,et al, 1988
Atrial Fibrillation and Stroke:New Ideas, Persisting Dilemmas
Stroke 19:937-941, Halperin,J.L.&Hart,R.G., 1988
Cooperative Study on the Value of Long Term Anticoagulation in Pts with Stroke & Non-Rheumatic Atrial Fibrillation
BMJ 296:1435-1438, Lodder,J.,et al, 1988
Brain Cardioembolism, Issues in Diagnosis & Management
Postgrad Med 82:48-57, Anderson,D.C., 1987
Acute Arsenic Intoxication Presenting as Guillain-Barre-Like Syndrome:Donofrio
P. D. , et al, Muscle & Nerve 10:114-120, , 1987
Prognosis of Dementia in Normal-Pressure Hydrocephalus After a Shunt Operation
Ann Neurol 20:304-310, Thomsen,A.M.,et al, 1986
Inflammatory Myopathies
Ann Neurol 17:215-227, 317-3231985., Mastaglia,F.L.,et al, 1985
Aortic Saddle Embolus, A Twenty-Year Experience
Ann Surg 197:698-706, Busuttil,R.W.,et al, 1983
The Malignant Hyperthermia Syndrome
NEJM 309:416-418, Nelson,T.E.,et al, 1983
Treatment of Acromegaly
BMJ 286:330-332, Thomas,J.P., 1983